Fluorine-18 Chemistry for Molecular Imaging with Positron Emission Tomography

Fluorine and Health: Molecular Imaging, Biomedical Materials and Pharmaceuticals

Volumn , Issue , 2008, Pages 3-65

  Dollé, Frédéric ^a   Roeda, Dirk ^a   Kuhnast, Bertrand ^a   Lasne, Marie Claire ^b  

^a Service Hospitalier Frric Joliot   (France)

^b La Mirada Eye and Laser Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84983778506     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-444-53086-8.00001-1     Document Type: Chapter

References (286)

1. Valk P.E., Bailey D.L., Townsend D.W., Maisey M.N. Positron Emission Tomography-Basic Science and Clinical Practice 2003, Springer, London - Berlin - Heidelberg - New York - Hong Kong - Milan - Paris - Tokyo.
2. Stöcklin G., Pike V.W. Radiopharmaceuticals for Positron Emission Tomography 1993, Kluwer Academic Publishers, Dordrecht - Boston - London.
3. Welch M.J., Redvanly C.S. Handbook of Radiopharmaceuticals-Radiochemistry and Applications 2003, Wiley, Chichester.
4. Browne E., Dairiki J.M., Doebler R.E. Table of Isotopes 1978, Wiley-Interscience Publishers, New York - Chichester - Brisbane - Toronto.
5. Welch M.J. Radiopharmaceuticals and other Compounds Labeled with Short-Lived Radionuclides 1977, Pergamon Press, Oxford - New York - Toronto - Sydney - Paris - Frankfurt.
6. Kilbourn M.R., Welch M.J. Fluorine-18 labeled receptor based radiopharmaceuticals. Appl. Radiat. Isot. 1986, 37:677-683.
7. Kilbourn M.R. Fluorine-18 Labeling of Radiopharmaceuticals 1990, Nuclear Science Series, Washington.
8. +-emitting compounds based on fluorine-18. Topics in Current Chemistry 2002, Vol. 222:201-258. Springer-Verlag, Berlin - Heidelberg. W. Krause (Ed.).
9. Mason N.S., Mathis C.A. Radiohalogens for PET imaging. Positron Emission Tomography-Basic Science and Clinical Practice 2003, 217-236. Springer, London - Berlin - Heidelberg - New York - Hong Kong - Milan - Paris - Tokyo. P.E. Valk, D.L. Bailey, D.W. Townsend, M.N. Maisey (Eds.).
10. Kilbourn M.R., Dence C.S., Welch M.J., Mathias C.J. Fluorine-18 labeling of proteins. J. Nucl. Med. 1987, 28:462-470.
11. Wilbur D.S. Radiohalogenation of proteins: An overview of radionuclides, labeling methods, and reagents for conjugate labeling. Bioconj. Chem. 1992, 3:433-470.
12. Okarvi S.M. Recent progress in fluorine-18 labelled peptide radiopharmaceuticals. Eur. J. Nucl. Med. 2001, 28:929-938.
13. 18F]fluoropyridine-based maleimide reagent for the labeling of peptides and proteins. Bioconj. Chem. 2005, 16:406-420.
14. 18F for in vivo PET imaging. J. Label. Compds Radiopharm. 1997, 39:319-330.
15. Tavitian B., Terrazzino S., Kuhnast B., Marzabal S., Stettler O., Dollé F., Deverre J.R., Jobert A., Hinnen F., Bendriem B., Crouzel C., DiGiamberardino L. In vivo imaging of oligonucleotides with positron emission tomography. Nat. Med. 1998, 4:467-471.
16. Tavitian B. In vivo imaging with oligonucleotides for diagnosis and drug development. Gut 2003, 52:40-47.
17. Tavitian B. Oligonucleotides as radiopharmaceuticals. Molecular Imaging 2004, Vol. 49:1-34. Springer-Verlag, Berlin - Heidelberg - New York. Ernst Schering Research Foundation (Ed.).
18. 18F]fluoro-pyridin-3-yloxy)-propyl]-acetamide. Bioconj. Chem. 2004, 15:617-627.
19. Qaim S.M., Stöcklin G. Production of some medically important short-lived neutron-deficient radioisotopes of halogens. Radiochim. Acta 1983, 34:25-40.
20. Stöcklin G.L. Is there a future for clinical fluorine-18 radiopharmaceuticals (excluding FDG)?. Eur. J. Nucl. Med. 1998, 25:1612-1616.
21. 18F-Labeled radiopharmaceuticals for PET in oncology, excluding FDG. Nucl. Med. Biol. 2000, 27:103-112.
22. Matsson O., Persson J., Axelsson B.S., Långström B. Fluorine kinetic isotope effects. J. Am. Chem. Soc. 1993, 115:5288-5289.
23. Fowler J.S., Wolf A.P. Positron-emitter-labeled compounds: Priorities and problems. Positron Emission Tomography and Autoradiography: Principles and Applications for the Brain and Heart 1986, 391-450. Raven Press, New York. M. Phelps, J. Mazziotta, H. Schelbert (Eds.).
24. Bondi A. Van der Waals volumes and radii. J. Phys. Chem. 1964, 68:441-451.
25. Hiyama T. Organofluorine Compounds-Chemistry and Applications 2000, Springer, Berlin - Heidelberg - New York - Barcelona - Hong Kong - London - Milan - Paris - Singapore - Tokyo.
26. Smart B.E. Fluorine substituent effetcs (on bioactivity). J. Fluor. Chem. 2001, 109:3-11.
27. CRC Handbook of Chemistry and Physics 1984, CRC Press Inc., Boca Raton. 65th edition. R.C. Weast, M.J. Astle (Eds.).
28. Clark J.H., Miller J.M. Hydrogen bonding in organic synthesis. 3. Hydrogen bond assisted reactions of cyclic organic hydrogen bound electron acceptors with halogenoalkanes in presence of potassium fluoride. J. Am. Chem. Soc. 1977, 99:498-504.
29. Dollé F. Fluorine-18-labelled fluoropyridines: Advances in radiopharmaceutical design. Curr. Pharm. Des. 2005, 11:3221-3235.
30. Långström B., Kihlberg T., Bergström M., Antoni G., Björkman M., Forngren B.H., Forngren T., Hartvig P., Markides K., Yngve U., Ogren M. Compounds labelled with short-lived beta-plus-emitting radionuclides and some applications in life sciences. The importance of time as a parameter. Acta Chem. Scand. 1999, 53:651-669.
31. Alexoff D.L. Automation for the synthesis and application of PET radiopharmaceuticals. Handbook of Radiopharmaceuticals-Radiochemistry and Applications 2003, 283-305. Wiley, Chichester. M.J. Welch, C.S. Redvanly (Eds.).
32. Schlyer D.J. Production of radionuclides in accelerators. Handbook of Radiopharmaceuticals-Radiochemistry and Applications 2003, 1-70. Wiley, Chichester. M.J. Welch, C.S. Redvanly (Eds.).
33. Ruth T.J. Accelerators available for isotope production. Handbook of Radiopharmaceuticals-Radiochemistry and Applications 2003, 71-86. Wiley, Chichester. M.J. Welch, C.S. Redvanly (Eds.).
34. Mausner L.F., Mirzadeh S. Reactor production of radionuclides. Handbook of Radiopharmaceuticals-Radiochemistry and Applications 2003, 86-118. Wiley, Chichester. M.J. Welch, C.S. Redvanly (Eds.).
35. 18F reaction. Radiochim. Acta 1979, 26:21-25.
36. Guillaume M., Luxen A., Nebeling B., Argentini M., Clark J., Pike V.W. Recommendations for F-18 production. Appl. Radiat. Isot. 1991, 42:749-762.
37. 2. Appl. Radiat. Isot. 1984, 35:117-122.
38. Bergman J., Solin O. Fluorine-18-labeled fluorine gas for synthesis of tracer molecules. Nucl. Med. Biol. 1997, 24:677-683.
39. Elsinga P.H. Radiopharmaceutical chemistry for positron emission tomography. Methods 2002, 27:208-217.
40. 18F: Labeling chemistry and labeled compounds. Handbook of Nuclear Chemistry 2003, Vol. 4:167-209. Kluwer Academic Publishers, Dordrecht. A. Vertes (Ed.).
41. Ferrieri R.A. Production and application of synthetic precursors labeled with carbon-11 and fluorine-18. Handbook of Radiopharmaceuticals-Radiochemistry and Applications 2003, 229-282. Wiley, Chichester. M.J. Welch, C.S. Redvanly (Eds.).
42. Snyder S.E., Kilbourn M.R. Chemistry of fluorine-18 radiopharmaceuticals. Handbook of Radiopharmaceuticals-Radiochemistry and Applications 2003, 195-228. Wiley, Chichester. M.J. Welch, C.S. Redvanly (Eds.).
43. 18F. Int. J. Appl. Radiat. Isot. 1968, 19:27-32.
44. 2, HF (F-18) and F-18 (aq) using the Ne-20(d,alpha)F-18 process. Appl. Radiat. Isot. 1986, 37:1135-1139.
45. 18F-fluorinating intermediates. Int. J. Appl. Radiat. Isot. 1978, 29:175-183.
46. 18F-hydrofluoric acid. Int. J. Appl. Radiat. Isot. 1978, 29:407-408.
47. Clark J.C., Oberdorfer F. Thermal characteristics of the release of fluorine-18 from an iconel-600 gas target. J. Label. Compds Radiopharm. 1982, 19:1337.
48. Helus F., Maierborst W., Sahm U., Wiebe L.I. F-18 Cyclotron production methods. Radiochem. Radioanal. Lett. 1979, 38:395-410.
49. 18F. J. Label. Compds Radiopharm. 1982, 19:1620-1622.
50. Clark J.C., Goulding R.W., Roman M., Palmer A.J. Preparation of fluorine-18-labeled compounds using a recirculatory neon target. Radiochem. Radioanal. Lett. 1973, 14:101-108.
51. Dahl J.R., Lee R., Bigler R.E., Schmall B., Aber J.E. A new target system for the preparation of no-carrier-added F-18 fluorinated compounds. Int. J. Appl. Radiat. Isot. 1983, 34:693-700.
52. 18F by deuteron irradiation of a neon-hydrogen gas-target. Radiochim. Acta 1983, 33:49-56.
53. 18F-fluoride in organic solvents: Production and labeling results. J. Label. Compds Radiopharm. 1982, 19:1639-1640.
54. Berridge M.S., Crouzel C., Comar D. Aromatic fluorination with n.c.a. fluoride: A comparative study. J. Label. Compds Radiopharm. 1985, 22:687-694.
55. Briard E., Pike V.W. Substitution-reduction: An alternative process for the [F-18]N-(2-fluoroethylation) of anilines. J. Label. Compds Radiopharm. 2004, 47:217-232.
56. 18F]flumazenil via instant fluorination, a new nucleophilic fluorination method. J. Label. Compds Radiopharm. 2001, 44:S930-S932.
57. Straatmann M.G., Welch M.J. 18F-labeled diethylaminosulfur trifluoride. DAST: An F-for-OH fluorinating agent. J. Nucl. Med. 1977, 18:151-158.
58. 18F-sugar. J. Label. Compds Radiopharm. 1977, 13:210.
59. Schrobilgen G., Firnau G., Chirakal R., Garnett E.S. Synthesis of xenon difluoride-18F, a novel agent for the preparation of fluorine-18 radiopharmaceuticals. J. Chem. Soc. Chem. Comm. 1981, 4:198-199.
60. 18F]fluoro-DOPA. J. Label. Compds Radiopharm. 1981, 18:7-8.
61. 18F-2-fluoro-2-deoxy-d-glucose. Int. J. Appl. Radiat. Isot. 1983, 34:743-746.
62. Shiue C.Y., To K.C., Wolf A.P. A rapid synthesis of 2-deoxy-2-fluoro-d-glucose from xenon difluoride suitable for labelling with 18F. J. Label. Compds Radiopharm. 1983, 20:157-162.
63. 18F]perchlorylfluoride. J. Label. Compds Radiopharm. 2001, 44:S901.
64. Choe Y.S., Lidström P.J., Chi D.Y., Bonasera T.A., Welch M.J., Katzenellenbogen J.A. Synthesis of 11-beta-[F-18]fluoro-5-alpha-dihydrotestosterone and 11-beta-[F-18]fluoro-19-nor-5-alpha-dihydrotestosterone-Preparation via halofluorination-reduction, receptor-binding, and tissue distribution. J. Med. Chem. 1995, 38:816-825.
65. Choe Y.S., Bonasera T.A., Chi D.Y., Welch M.J., Katzenellenbogen J.A. 6-alpha-[F-18]fluoroprogesterone-Synthesis via halofluorination-oxidation, receptor-binding and tissue distribution. Nucl. Med. Biol. 1995, 22:635-642.
66. Chi D.Y., Lidström P.J., Choe Y.S., Bonasera T.A., Welch M.J., Katzenellenbogen J.A. Bromo[F-18]fluorination of cyclohexenes-A method for the preparation of [F-18]fluorocyclohexanes. J. Fluor. Chem. 1995, 71:143-147.
67. 18F reaction via fluorine-18 labeled nitrosyl fluoride. A selective fluorinating agent. J. Nucl. Med. 1971, 12:405.
68. Rozen S. Elemental fluorine as a legitimate reagent for selective fluorination of organic compounds. Acc. Chem. Res. 1988, 21:307-312.
69. Wilkinson J.A. Recent advances in the selective formation of the C-F bond. Chem. Rev. 1992, 92:505-519.
70. 18F-radiopharmaceuticals. Appl. Radiat. Isot. 1986, 37:685-694.
71. Casella V., Ido T., Wolf A.P., Fowler J.S., MacGregor R.R., Ruth T.J. Anhydrous F-18 labeled elemental fluorine for radiopharmaceutical preparation. J. Nucl. Med. 1980, 21:750-757.
72. 2 production using the neon/fluorine target. J. Nucl. Med. 1980, 21:758-762.
73. Chambers R.D., Skinner C.J., Hutchinson J., Thomson J. Elemental fluorine. 1. Synthesis of fluoroaromatic compounds. J. Chem. Soc. Perkin Trans. 1996, 1:605-609.
74. Moilliet J.S. The use of elemental fluorine for selective direct fluorinations. J. Fluor. Chem. 2001, 109:13-17.
75. 18F-fluorinating intermediate-trifluoromethyl hypofluorite. Int. J. Appl. Radiat. Isot. 1978, 29:323-327.
76. 18F-labeled acetyl hypofluorite. J. Nucl. Med. 1982, 23:899-903.
77. 18F-2-fluoro-2-deoxy-d-glucose. Nuklearmedizin 1984, (suppl. 21):823-825.
78. Ehrenkaufer R.E., Potocki J.F., Jewett D.M. Simple synthesis of F-18-labeled 2-fluoro-2-deoxy-d-glucose. J. Nucl. Med. 1984, 25:333-337.
79. 18F]-perchloryl fluoride and its reactions with functionalized aryllithiums. Int. J. Appl. Radiat. Isot. 1983, 34:613-615.
80. 18F]fluorine gas. Int. J. Appl. Radiat. Isot. 1984, 35:401-404.
81. 18F]xenon difluoride for PET and mechanistic studies. J. Am. Chem. Soc. 2001, 123:1780-1781.
82. 18F]fluoro-2-pyridone. Appl. Radiat. Isot. 1988, 39:685-688.
83. Oberdorfer F., Hofmann E., Maier-Borst W. Preparation of 18F-labeled N-fluoropyridinium triflate. J. Label. Compds Radiopharm. 1988, 25:999-1005.
84. 18F]fluoro-N-alkylsulfonamides: Novel reagents for mild and regioselective radiofluorination. Appl. Radiat. Isot. 1990, 41:733-738.
85. Smith M.B., March J. March's Advanced Organic Chemistry-Reactions, Mechanisms, and Structure 2001, Wiley-Interscience Pub, New York - Chichester - Brisbane - Toronto. 5th edition.
86. Ido T., Wan C.N., Casella V., Fowler J.S., Wolf A.P., Reivich M., Kuhl D.E. Labeled 2-deoxy-d-glucose analogs-F-18-labeled 2-deoxy-2-fluoro- d-glucose, 2-deoxy-2-fluoro- d-mannose and C-14-2-deoxy-2-fluoro- d-glucose. J. Label. Compds Radiopharm. 1978, 14:175-183.
87. 18F]fluoro-2-deoxy-d-glucose using glycals: A reexamination. J. Nucl. Med. 1984, 25:1327-1334.
88. Ashique R., Chirakal R.V., Hughes D.W., Schrobilgen G.J. Two-step regio- and stereoselective syntheses of [F-19]- and [F-18]-2-deoxy-2-(R)-fluoro-beta-d-allose. Carbohyd. Res. 2006, 341:457-466.
89. 18F]difluoropalmitic acid, and biodistribution in rats. Nucl. Med. Biol. 1990, 17:805-809.
90. 18F]EF5, a marker for PET detection of hypoxia: Synthesis of precursor and a new fluorination procedure. Appl. Radiat. Isot. 2001, 54:73-80.
91. 18F-5-fluorouracil. J. Nucl. Med. 1973, 14:63-64.
92. 18F-5-fluorouracil. Int. J. Appl. Radiat. Isot. 1979, 30:401-405.
93. 18F-labelled 5-fluorouracil using acetylhypofluorite. Nucl. Med. Biol. 1984, 11:141-142.
94. 18F-labelled 5-fluorouracil of very high purity. J. Label. Compds Radiopharm. 1989, 27:137-145.
95. 18F-fluorouridine and related compounds as probe for measuring tissue proliferation in vivo. J. Label. Compds Radiopharm. 1984, 21:865-873.
96. 18F]fluoro-2?-deoxyuridine. J. Label. Compds Radiopharm. 1984, 21:1231-1233.
97. 18F]fluoro-2?-deoxyuridine. Appl. Radiat. Isot. 1987, 38:467-473.
98. 18F]-fluorouridine as a probe for measuring tissue proliferation in vivo. J. Label. Compds Radiopharm. 1982, 19:1395.
99. 18F-labelled cytosine- and uracil-nucleosides. Appl. Radiat. Isot. 1986, 37:1074-1076.
100. Luxen A., Barrio J.R., Satyamurthy N., Bida G.T., Phelps M.E. Electrophilic and nucleophilic approaches to the synthesis of 3-fluorodiazepam. J. Fluor. Chem. 1987, 36:83-92.
101. 18F]-labeled alpha-trifluoromethyl ketones. J. Label. Compds Radiopharm. 2003, 46:1087-1092.
102. Firnau G., Chirakal R., Garnett E.S. Aromatic radiofluorination with [F-18]fluorine-gas-6-[F-18]fluoro-l-DOPA. J. Nucl. Med. 1984, 25:1228-1233.
103. Coenen H.H., Franken K., Kling P., Stöcklin G. Direct electrophilic radiofluorination of phenylalanine, tyrosine and DOPA. Appl. Radiat. Isot. 1988, 39:1243-1250.
104. Chirakal R., Vasdev N., Schrobilgen G.J., Nahmias C. Radiochemical and NMR spectroscopic investigation of the solvent effect on the electrophilic elemental fluorination of l-DOPA: Synthesis of [F-18]5-fluoro-l-DOPA. J. Fluor. Chem. 1999, 99:87-94.
105. Vaalburg W., Coenen H.H., Crouzel C., Elsinga P.H., Långström B., Lemaire C., Meyer G.J. Amino acids for the measurement of protein synthesis in vivo by PET. Nucl. Med. Biol. 1992, 19:227-237.
106. Ogawa M., Hatano K., Oishi S., Kawasumi Y., Fujii N., Kawaguchi M., Doi R., Imamura M., Yamamoto M., Ajito K., Mukai T., Saji H., Ito K. Direct electrophilic radiofluorination of a cyclic RGD peptide for in vivo alpha(v)beta(3) integrin related tumor imaging. Nucl. Med. Biol. 2003, 30:1-9.
107. Namavari M., Barrio J.R., Toyokuni T., Gambhir S.S., Cherry S.R., Herschman H.R., Phelps M.E., Satyamurthy N. Synthesis of 8-[F-18]fluoroguanine derivatives: In vivo probes for imaging gene expression with positron emission tomography. Nucl. Med. Biol. 2000, 27:157-162.
108. 18F]fluorouracil. J. Label. Compds Radiopharm. 1995, 37:135-136.
109. 2 gas as a tumor imaging agent. Bull. Kor. Chem. Soc. 2005, 26:1865-1868.
110. Coenen H.H., Moerlein S.M. Regiospecific aromatic fluorodemetallation of group IVb metalloarenes using elemental fluorine or acetyl hypofluorite. J. Fluor. Chem. 1987, 36:63-75.
111. 18F]Fluorometaraminol: A radiotracer for in vivo mapping of adrenergic nerves of the heart. J. Med. Chem. 1988, 31:362-366.
112. 18F]fluorometaraminol, a tracer for the assessment of cardiac sympathetic nerve integrity with PET. Nucl. Med. Biol. 2004, 31:103-110.
113. 18F]fluorometaraminol-PET tracers for the adrenergic nervous system of the heart. Bioorg. Med. Chem. 2001, 9:677-694.
114. Adam M.J., Berry J.M., Hall L.D., Pate B.D., Ruth T. The cleavage of aryl-metal bonds by elemental fluorine-Synthesis of aryl-fluorides. Can. J. Chem. 1983, 61:658-660.
115. Adam M.J., Jivan S. Synthesis and purification of l-6-[F-18]fluoro-DOPA. Appl. Radiat. Isot. 1988, 39:1203-1206.
116. Luxen A., Perlmutter M., Bida G.T., Van Moffaert G., Cook J.S., Satyamurthy N., Phelps M.E., Barrio J.R. Remote, semiautomated production of 6-[F-18]fluoro-l-DOPA for human studies with PET. Appl. Radiat. Isot. 1990, 41:275-281.
117. Dollé F., Demphel S., Hinnen F., Fournier D., Vaufrey F., Crouzel C. 6-[F-18]Fluoro-l-DOPA by radiofluorodestannylation: A short and simple synthesis of a new labelling precursor. J. Label. Compds Radiopharm. 1998, 41:105-114.
118. de Vries E.F.J., Luurtsema G., Brüssermann M., Elsinga P.H., Vaalburg W. Fully automated synthesis module for the high yield one-pot preparation of 6-[F-18]fluoro-l-DOPA. Appl. Radiat. Isot. 1999, 51:389-394.
119. 18F]fluoro-l-DOPA preparation: Precursor synthesis, preparative HPLC purification and determination of radiochemical purity. Nucl. Med. Biol. 2002, 29:477-481.
120. 3COOF-A high-yield synthesis of 6-[F-18]fluoro-l-DOPA. Appl. Radiat. Isot. 1992, 43:989-996.
121. 18F]WIN 35,428), a radioligand to study the dopamine transporter with PET: Biodistribution in rats. Synapse 1996, 23:321-327.
122. Rinne O., Ruottinen H., Bergman J., Haaparanta M., Sonninen P., Solin O. Usefulness of a dopamine transporter PET ligand [F-18]beta-CFT in assessing disability in Parkinson's disease. J. Neurol. Neurosur. Psych. 1999, 67:737-741.
123. Namavari M., Satyamurthy N., Barrio J.R. Synthesis of 6-[F-18]fluorodopamine, 6-[F-18]fluoro-m-tyramine and 4-[F-18]fluoro-m-tyramine. J. Label. Compds Radiopharm. 1995, 36:825-833.
124. Hess E., Sichler S., Kluge A., Coenen H.H. Synthesis of 2-[18F]fluoro-L-tyrosine via regiospecific fluoro-de-stannylation. Appl. Radiat. Isot. 2002, 57:185-191.
125. Duelfer T., Johnström P., Stone-Elander S., Holland A., Halldin C., Haaparanta M., Solin O., Bergman J., Steinman M., Sedvall G. The labeling of 2-oxoquazepam with electrophilic F-18. J. Label. Compds Radiopharm. 1991, 29:1223-1239.
126. 18F]fluoro-1,2,3,4-tetrahydroacridine: A potential PET agent for evaluating acetylcholinesterase. J. Label. Compds Radiopharm. 1999, 42:S539-S540.
127. 18F]fluorobenzidine: A precursor to bisdiazodyes: Potential radioligands to image amyloid deposits in the brain of alzheimer patients. J. Label. Compds Radiopharm. 1999, 42:S541-S542.
128. Clark J.H. Fluoride-ion as a base in organic-synthesis. Chem. Rev. 1980, 80:429-452.
129. Katsifis A., Hamacher K., Schnitter J., Stöcklin G. Optimization studies concerning the direct nucleophilic fluorination of butyrophenone neuroleptics. Appl. Radiat. Isot. 1993, 44:1015-1020.
130. Hamacher K., Hamkens W. Remote-controlled one-step production of F-18 labeled butyrophenone neuroleptics exemplified by the synthesis of nca [F-18]N-methylspiperone. Appl. Radiat. Isot. 1995, 46:911-916.
131. -. J. Label. Compds Radiopharm. 1983, 20:501-514.
132. 18F-labeled butyrophenone neuroleptics: Benperidol, haloperidol, spiroperidol and pipamperone. J. Nucl. Med. 1985, 26:181-186.
133. 18F-labeled radioligands. J. Label. Compds Radiopharm. 1986, 23:1038-1039.
134. Shiue C.Y., Fowler J.S., Wolf A.P., McPherson D.W., Arnett C.D., Zecca L. No-carrier-added fluorine-18 labeled N-methylspiperidol: Synthesis and biodistribution in mice. J. Nucl. Med. 1986, 27:226-234.
135. Brodack J.W., Dence C.S., Kilbourn M.R., Welch M.J. Robotic production of 2-deoxy-2-[F-18]fluoro-d-glucose-A routine method of synthesis using tetrabutylammonium [F-18] fluoride. Appl. Radiat. Isot. 1988, 39:699-703.
136. Cox D.P., Terpinski J., Lawrynowicz W. Anhydrous tetrabutylammonium fluoride-A mild but highly efficient source of nucleophilic fluoride-ion. J. Org. Chem. 1984, 49:3216-3219.
137. Sharma R.K., Fry J.L. Instability of anhydrous tetra-normal-alkylammonium fluorides. J. Org. Chem. 1983, 48:2112-2114.
138. Irie T., Fukushi K., Ido T., Nozaki T., Kasida Y. F-18-labeled fluorination by crown ether metal fluoride. 1. On labeling F-18-21-fluoroprogesterone. Int. J. Appl. Radiat. Isot. 1982, 33:1449-1452.
139. 18F]-fluoro-2-deoxy-d-glucose using aminopolyether supported nucleophilic substitution. J. Nucl. Med. 1986, 27:235-238.
140. 17-18F]fluoroheptadecanoic acid in high yields via aminopolyether supported, nucleophilic fluorination. J. Label. Compds Radiopharm. 1986, 23:455-467.
141. Block D., Coenen H.H., Stöcklin G. The N.C.A. nucleophilic 18F-fluorination of 1,N-disubstituted alkanes as fluoroalkylation agents. J. Label. Compds Radiopharm. 1987, 24:1029-1042.
142. Zheng L., Berridge M.S. Synthesis of [F-18]fluoromethyl iodide, a synthetic precursor for fluoromethylation of radiopharmaceuticals. Appl. Radiat. Isot. 2000, 52:55-61.
143. 18F-labeled choline as an oncologic tracer for positron emission tomography: Initial findings in prostate cancer. Cancer Res. 2001, 61:110-117.
144. 18F]LBT-999, a selective radioligand for the visualisation of the dopamine transporter with PET. J. Label. Compds Radiopharm. 2006, 49:687-698.
145. 18F]fluoropropyl)-2,3-dimethoxybenzamide as an improved dopamine D-2 receptor tracer. Nucl. Med. Biol. 1995, 22:283-296.
146. 18FDG). Handbook of Radiopharmaceuticals-Radiochemistry and Applications 2003, 307-322. Wiley, Chichester. M.J. Welch, C.S. Redvanly (Eds.).
147. 18F]FDG using an alkaline hydrolysis on solid support. J. Label. Compds Radiopharm. 1999, 42:S515-S516.
148. 18F]FDG produced by an alkaline hydrolysis on solid support under stringent conditions. Appl. Radiat. Isot. 2002, 56:871-875.
149. 18F]FDG synthesis by alkaline hydrolysis on a low polarity solid phase support. J. Label. Compds Radiopharm. 2002, 45:435-447.
150. Lee C.C., Sui G., Elizarov A., Shu C.J., Shin Y.S., Dooley A.N., Huang J., Daridon A., Wyatt P., Stout D., Kolb H.C., Witte O.N., Satyamurthy N., Heath J.R, Phelps M.E., Quake S.R., Tseng H.R. Multistep synthesis of a radiolabeled imaging probe using integrated microfluidics. Science 2005, 310:1793-1796.
151. Gillies J.M., Prenant C., Chimon G.N., Smethurst G.J., Perrie W., Hambletta I., Dekker B., Zweit J. Microfluidic reactor for the radiosynthesis of PET radiotracers. Appl. Radiat. Isot. 2006, 64:325-332.
152. Machulla H.J., Blocher A., Kuntzsch M., Piert M., Wei R., Grierson J.R. Simplified labeling approach for synthesizing 3deoxy-3[F-18]fluorothymidine ([F-18]FLT). J. Radioanal. Nucl. Chem. 2000, 243:843-846.
153. Wodarski C., Eisenbarth J., Weber K., Henze M., Haberkorn U., Eisenhut M. Synthesis of 3?-deoxy-3?-[F-18]fluoro-thymidine with 2,3?-anhydro-5?-O-(4,4?-dimethoxytrityl)thymidine. J. Label. Compds Radiopharm. 2000, 43:1211-1218.
154. Teng B., Wang S.Z., Fu Z., Dang Y.H., Wu Z.H., Liu L.Q. Semiautomatic synthesis of 3?-deoxy-3?-[F-18]fluorothymidine using three precursors. Appl. Radiat. Isot. 2006, 64:187-193.
155. Kämärainen E.L., Kyllonen T., Nihtilä O., Björk H., Solin O. Preparation of fluorine-18-labeled fluoromisonidazole using two different synthesis methods. J. Label. Compds Radiopharm. 2004, 47:37-45.
156. 18F]fluoro-l-proline, radiotracers for PET-investigation of disordered matrix protein synthesis. J. Label. Compds Radiopharm. 1999, 42:1135-1144.
157. 18F]fluoroethyl)-l-tyrosine. Appl. Radiat. Isot. 2002, 57:853-856.
158. 18F]fluorothymidine. Nucl. Med. Biol. 2004, 31:803-809.
159. 18F]FDG module. Nucl. Med. Biol. 2005, 32:899-905.
160. Blocher A., Kuntzsch M., Wei R., Machulla H.J. Synthesis and labeling of 5O(4,4dimethoxytrityl)-2,3-anhydrothymidine for [F-18]FLT preparation. J. Radioanal. Nucl. Chem. 2002, 251:55-58.
161. Lim J.L., Zheng L., Berridge M.S., Tewson T.J. The use of 3-methoxymethyl-16?,17b-epiestriol-O-cyclic sulfone as the precursor in the synthesis of F-18 16?-fluoroestradiol. Nucl. Med. Biol. 1996, 23:911-915.
162. Van Dort M.E., Jung Y.W., Sherman P.S., Kilbourn M.R., Wieland D.M. Fluorine for hydroxy substitution in biogenic amines: Asymmetric synthesis and biological evaluation of fluorine-18-labeled beta-fluorophenylalkylamines as model systems. J. Med. Chem. 1995, 38:810-815.
163. McConathy J., Martarello L., Malveaux E.J., Camp V.M., Simpson N.E., Simpson C.P., Bowers G.D., Olson J.J., Goodman M.M. Radiolabeled amino acidsfor tumor imaging with PET: Radiosynthesis and biological evaluation of 2-amino-3-[F-18]fluoro-2-methylpropanoic acid and 3-[F-18]fluoro-2-methyl-2-(methylamino)propanoic acid. J. Med. Chem. 2002, 45:2240-2249.
164. Seimbille Y., Rousseau J., Benard F., Morin C., Ali H., Avvakumov G., Hammond G.L., van Lier J.E. F-18-labeled difluoroestradiols: Preparation and preclinical evaluation as estrogen receptor-binding radiopharmaceuticals. Steroids 2002, 67:765-775.
165. Seimbille Y., Benard F., Rousseau J., Pepin E., Aliaga A., Tessier G., van Lier J.E. Impact on estrogen receptor binding and target tissue uptake of [F-18]fluorine substitution at the 16-alpha-position of fulvestrant. Nucl. Med. Biol. 2004, 31:691-698.
166. 18F]fluoro-l-ascorbic acid. Appl. Radiat. Isot. 1992, 43:633-639.
167. Angelini G., Speranza M., Wolf A.P., Shiue C.Y. Nucleophilic aromatic-substitution of activated cationic groups by F-18-labeled fluoride-A useful route to no-carrier-added (nca) F-18-labeled aryl fluorides. J. Fluor. Chem. 1985, 27:177-191.
168. Haka M.S., Kilbourn M.R., Watkins L., Toorongian S.A. Aryltrimethylammonium trifluoromethanesulfonates as precursors to aryl [F-18] fluorides-Improved synthesis of [F-18]GBR-13119. J. Label. Compds Radiopharm. 1989, 27:823-833.
169. 18F]fluoride ion?. J. Label. Compds Radiopharm. 1993, 33:563-572.
170. Stone-Elander S., Elander N. Microwave applications in radiolabelling with short-lived positron-emitting radionuclides. J. Label. Compds Radiopharm. 2002, 45:715-746.
171. Stone-Elander S., Elander N. Microwave cavities: Some parameters affecting their use in radiolabeling reactions. Appl. Radiat. Isot. 1991, 42:885-887.
172. Elander N., Jones J.R., Lu S.Y., Stone-Elander S. Microwave-enhanced radiochemistry. Chem. Soc. Rev. 2000, 29:239-249.
173. Hwang D.R., Moerlein S.M., Lang L., Welch M.J. Application of microwave technology to the synthesis of short-lived radiopharmaceuticals. J. Chem. Soc. Chem. Comm. 1987, 23:1799-1801.
174. Lemaire C., Guillaume M., Christiaens L., Palmer A.J., Cantineau R. A new route for the synthesis of [F-18]fluoroaromatic substituted amino-acids-No carrier added l-p-[F-18]fluorophenylalanine. Appl. Radiat. Isot. 1987, 38:1033-1038.
175. Lemaire C., Damhaut P., Plevenaux A., Cantineau R., Christiaens L., Guillaume M. Synthesis of F-18 substituted aromatic-aldehydes and benzyl bromides, new intermediates for nca [F-18] fluorination. Appl. Radiat. Isot. 1992, 43:485-494.
176. Ding Y.S., Shiue C.Y., Fowler J.S., Wolf A.P., Plevenaux A. No carrier added (nca) aryl [F-18]fluorides via the nucleophilic aromatic-substitution of electron-rich aromatic rings. J. Fluor. Chem. 1990, 48:189-205.
177. Najafi A., Peterson A., Buchsbaum M., O'Dell S., Weihmuller F. Preparation and preliminary biological evaluation of [F-18]NCQ-115-A new selective reversible dopamine D2 receptor ligand. Nucl. Med. Biol. 1993, 20:549-555.
178. Damhaut P., Cantineau R., Lemaire C., Plevenaux A., Christiaens L., Guillaume M. 2-[F-18]fluorotropapride and 4-[F-18]fluorotropapride, 2 specific D2-receptor ligands for positron emission tomography-NCA syntheses and animal studies. Appl. Radiat. Isot. 1992, 43:1265-1274.
179. Iwata R., Pascali C., Bogni A., Horvath G., Kovacs Z., Yanai K., Ido T. A new convenient method for the preparation of 4-[F-18]fluorobenzyl halides. Appl. Radiat. Isot. 2000, 52:87-92.
180. Iwata R., Horvath G., Pascali C., Bogni A., Yanai K., Kovacs Z., Ido T. Synthesis of 3-[1H-imidazol-4-yl]propyl 4-[F-18]fluorobenzyl ether ([F-18]fluoroproxyfan): A potential radioligand for imaging histamine H-3 receptors. J. Label. Compds Radiopharm. 2000, 43:872-893.
181. 18F]fluorobenzyl bromides and their application to the preparation of labeled neuroleptics. J. Label. Compds Radiopharm. 1991, 29:373-380.
182. Lemaire C., Damhaut P., Plevenaux A., Comar D. Enantioselective synthesis of 6-[fluorine-18]fluoro-l-DOPA from no-carrier-added fluorine-18-fluoride. J. Nucl. Med. 1994, 35:1996-2002.
183. Dence C.S., John C.S., Bowen W.D., Welch M.J. Synthesis and evaluation of [F-18]labeled benzamides: High affinity sigma receptor ligands for PET imaging. Nucl. Med. Biol. 1997, 24:333-340.
184. Halldin C., Högberg T., Farde L. Fluorine-18-labeled NCQ 115, a selective dopamine D-2 receptor ligand. Preparation and positron emission tomography. Nucl. Med. Biol. 1994, 21:627-631.
185. Mach R.H., Elder S.T., Morton T.E., Nowak P.A., Evora P.H., Scripko J.G., Luedtke R.R., Unsworth C.D., Filtz T., Rao A.V., Molinoff P.B., Ehrenkaufer R.L.E. The use of [F-18] 4-fluorobenzyl iodide (FBI) in PET radiotracer synthesis-Model alkylation studies and its application in the design of dopamine-D(1) and dopamine-D(2) receptor-based imaging agents. Nucl. Med. Biol. 1993, 20:777-794.
186. Ding Y.S., Fowler J.S., Wolf A.P. Rapid, regiospecific syntheses of deuterium substituted 6-[F-18]fluorodopamine (alpha, alpha-D2 beta, beta-D2 and alpha, alpha, beta, beta-D4) for mechanistic studies with positron emission tomography. J. Label. Compds Radiopharm. 1993, 31:645-654.
187. Hwang D.R., Dence C.S., McKinnon Z.A., Mathias C.J., Welch M.J. Positron labeled muscarinic acetylcholine-receptor antagonist-2-[F-18]Fluorodexetimide and 4-[F-18]fluorodexetimide-Synthesis and biodistribution. Nucl. Med. Biol. 1991, 18:247-252.
188. Kuhnast B., Dollé F., Vaufrey F., Hinnen F., Crouzel C., Tavitian B. Fluorine-18 labeling of oligonucleotides bearing chemically-modified ribose-phosphate backbones. J. Label. Compds Radiopharm. 2000, 43:837-848.
189. Kuhnast B., Dollé F., Terrazzino S., Rousseau B., Loc'h C., Vaufrey F., Hinnen F., Doignon I., Pillon F., David C., Crouzel C., Tavitian B. A general method to label antisense oligonucleotides with radioactive halogens for pharmacological and imaging studies. Bioconj. Chem. 2000, 11:627-636.
190. Allain-Barbier L., Lasne M.-C., Perrio-Huard C., Barre L. Synthesis of 4-[F-18]fluorophenylalkenes and -arenes via palladium-catalyzed coupling of 4-[F-18]fluoroiodobenzene with vinyl and aryl tin reagents. Acta Chem. Scand. 1998, 52:480-489.
191. Forngren T., Andersson Y., Lamm B., Långström B. Synthesis of [4-F-18]-1-bromo-4-fluorobenzene and its use in palladium-promoted cross-coupling reactions with organostannanes. Acta Chem. Scand. 1998, 52:475-479.
192. 18F]fluoroarenes. J. Chem. Soc. Chem. Comm. 1995, 21:2215-2216.
193. Shah A., Pike V.W., Widdowson D.A. The synthesis of [F-18]fluoroarenes from the reaction of cyclotron-produced [F-18]fluoride ion with diaryliodonium salts. J. Chem. Soc. Perkin Trans. I: Organic and Bio-Organic Chemistry 1998, 13:2043-2046.
194. 18F]fluorobenzene. J. Label. Compds Radiopharm. 2004, 47:429-441.
195. Lemaire C., Cantineau R., Guillaume M., Plenevaux A., Christiaens L. Fluorine-18-altanserin: A radioligand for the study of serotonin receptors with PET: Radiolabeling and in vivo biologic behavior in rats. J. Nucl. Med. 1991, 32:2266-2272.
196. Tan P.Z., Baldwin R.M., Soufer R., Garg P.K., Charney D.S., Innis R.B. A complete remote-control system for reliable preparation of [F-18]altanserin. Appl. Radiat. Isot. 1999, 50:923-927.
197. Tan P.Z., Baldwin R.M., Fu T., Charney D.S., Innis R.B. Rapid synthesis of F-18 and H-2 dual-labeled altanserin, a metabolically resistant PET ligand for 5-HT2A receptors. J. Label. Compds Radiopharm. 1999, 42:457-467.
198. 18F]Setoperone. J. Label. Compds Radiopharm. 1988, 25:403-414.
199. 18F. J. Label. Compds Radiopharm. 1990, 28:73-81.
200. Hashizume K., Hashimoto N., Miyake Y. Rapid and efficient synthesis of high-purity fluorine-18 labeled haloperidol and spiperone via the nitro precursor in combination with a new HPLC separation method. Bull. Chem. Soc. Japan 1997, 70:681-687.
201. 18F]MPPF, a fluoro analog of WAY-100635. Nucl. Med. Biol. 1998, 25:343-350.
202. 18F]fluoride. J. Label. Compds Radiopharm. 2005, 48:S145.
203. Hostetler E.D., Jonson S.D., Welch M.J., Katzenellenbogen J.A. Synthesis of 2-[F-18]fluoroestradiol, a potential diagnostic imaging agent for breast cancer: Strategies to achieve nucleophilic substitution of an electron-rich aromatic ring with [F-18]F. J. Org. Chem. 1999, 64:178-185.
204. Wüst F., Reul J.M.H.M., Rein T., Abel A., Stöcklin G. PET-corticosteroids as potential ligands for mapping brain glucocorticoid receptors (GR). J. Label. Compds Radiopharm. 2001, 44:S12-S14.
205. Wüst F., Carlson K.E., Katzenellenbogen J.A. Synthesis of novel arylpyrazolo corticosteroids as potential ligands for imaging brain glucocorticoid receptors. Steroids 2003, 68:177-191.
206. Horti A., Redmond D.E., Soufer R. No-carrier-added (nca) synthesis of 6-[F-18]fluoro-l-DOPA using 3,5,7,8,8a-hexahydro-7,7,8a-trimethyl-[6S-(6-alpha, 8-alpha, 8-alpha-beta]-6,8-methano-2H-1,4-benzoxazin-2-one. J. Label. Compds Radiopharm. 1995, 36:409-423.
207. 18F]fluorodopa via NCA nucleophilic fluorination. Appl. Radiat. Isot. 1991, 42:629-635.
208. 18F]fluoro-l-DOPA via two chiral auxiliaries. Appl. Radiat. Isot. 1993, 44:737-744.
209. Damhaut P., Lemaire C., Plevenaux A., Brihaye C., Christiaens L., Comar D. No-carrier-added asymmetric synthesis of alpha-methyl-alpha-amino acids labeled with fluorine-18. Tetrahedron 1997, 53:5785-5796.
210. Corey E.J., Xu F., Noe M.C., Mark C. A rational approach to catalytic enantioselective enolate alkylation using a structurally rigidified and defined chiral quaternary ammonium salt under phase transfer conditions. J. Am. Chem. Soc. 1997, 119:12414-12415.
211. Corey E.J., Noe M.C., Xu F. Highly enantioselective synthesis of cyclic and functionalized alpha-amino acids by means of a chiral phase transfer catalyst. Tetrahedron Lett. 1998, 39:5347-5350.
212. 18F]fluoro-l-DOPA by chiral phase-transfer alkylation. Eur. J. Org. Chem. 2004, 13:2899-2904.
213. 18F]fluoro-l-DOPA in semi-automated system. J. Label. Compds Radiopharm. 2001, 44:S868-S870.
214. Nozaki T., Tanaka Y. Preparation of F-18-labelled aryl fluorides. Int. J. Appl. Radiat. Isot. 1967, 18:111-119.
215. Palmer A.J., Clark J.C., Goulding R.W. Preparation of F-18 labeled radiopharmaceuticals. Int. J. Appl. Radiat. Isot. 1977, 28:53-65.
216. Palmer A.J., Clark J.C., Goulding R.W., Roman M. Preparation of fluorine-18-labeled DL-3-fluorotyrosine. Radiopharm. Label. Compds 1973, 1:291-302.
217. Argentini M., Wiese C., Weinreich R. Synthesis of 5-fluoro-d/l-DOPA and [F-18]5-fluoro-L-DOPA. J. Fluor. Chem. 1994, 68:141-144.
218. ?) by modified Balz-Schiemann-decomposition. Appl. Radiat. Isot. 1991, 42:1077-1080.
219. Knöchel A., Zwernemann O. Development of a no-carrier-added method for F-18-labelling of aromatic compounds by fluorodediazonation. J. Label. Compds Radiopharm. 1996, 38:325-336.
220. Tewson T.J., Welch M.J. Preparation of F-18 aryl fluorides-Piperidyl triazenes as a source of diazonium salts. J. Chem. Soc. Chem. Comm. 1979, 24:1149-1150.
221. Kilbourn M.R., Welch M.J., Dence C.S., Tewson T.J., Saji H., Maeda M. Carrier-added and no-carrier-added synthesis of [F-18]spiroperidol and [F-18]haloperidol. Int. J. Appl. Radiat. Isot. 1984, 35:591-598.
222. 18F]Fluoropyridines: From conventional radiotracers to the labelling of macromolecules such as proteins and oligonucleotides. PET Chemistry 2007, Vol. 62:111-143. Springer-Verlag, Berlin - Heidelberg - New York. Ernst Schering Research Foundation (Ed.).
223. 222-A comparative study. J. Label. Compds Radiopharm. 1999, 42:975-985.
224. 222-A comparative study. J. Label. Compds Radiopharm. 2003, 46:979-992.
225. Joule J.A., Mills K. Heterocyclic Chemistry 2000, Blackwell Science, Oxford - London - Edinburgh - Malden - Paris - Berlin - Tokyo. 4th edition.
226. 18F]nicotinic acid diethylamide. J. Label. Compds Radiopharm. 1982, 19:1643-1644.
227. 18F]nicotinic acid diethylamide, a potential agent for regional cerebral function studies. J. Radioanal. Chem. 1982, 74:283-291.
228. 18F-nicotinic acid diethylamide. Radiochem. Radioanal. Lett. 1983, 55:249-255.
229. 18F]fluoronicotine. Int. J. Appl. Radiat. Isot. 1984, 35:1125-1128.
230. Ding Y.S., Gatley J., Fowler J.S., Volkow N.D., Aggarwal D., Logan J., Dewey S.L., Liang F., Carroll F.I., Kuhar M.J. Mapping nicotinic acetylcholine receptors with PET. Synapse 1996, 24:403-407.
231. Liang F., Navarro H.A., Abraham P., Kotian P., Ding Y.S., Fowler J.S., Volkow N.D., Kuhar M.J., Carroll F.I. Synthesis and nicotinic acetylcholine receptor binding properties of exo-2-(2?-fluoro-5?-pyridinyl)-7-azabicyclo-[2.2.1]heptane: A new positron emission tomography ligand for nicotinic receptors. J. Med. Chem. 1997, 40:2293-2295.
232. 18F]norchlorofluoroepibatidine and its N-methyl derivative: New PET ligands for mapping nicotinic acetylcholine receptors. J. Label. Compds Radiopharm. 1997, 39:828-832.
233. Dolci L., Dollé F., Valette H., Vaufrey F., Fuseau C., Bottlaender M., Crouzel C. Synthesis of a fluorine-18 labelled derivative of epibatidine for in vivo nicotinic acetylcholine receptor PET imaging. Bioorg. Med. Chem. 1999, 7:467-479.
234. 18F]fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine, a highly potent radioligand for in vivo imaging central nicotinic acetylcholine receptors. J. Label. Compds Radiopharm. 1998, 41:451-463.
235. Dollé F., Dolci L., Valette H., Hinnen F., Vaufrey F., Guenther I., Fuseau C., Coulon C., Bottlaender M., Crouzel C. Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: A new positron emission tomography ligand for nicotinic receptors. J. Med. Chem. 1999, 42:2251-2259.
236. 18F]F-A-85380). J. Label. Compds Radiopharm. 1998, 41:309-318.
237. Irie T., Fukushi K., Inoue O., Yamasaki T., Kasida Y. 18F-labelled 6-fluoro-purine derivatives as a new type brain scanning agent. J. Label. Compds Radiopharm. 1982, 19:1641-1642.
238. Irie T., Fukushi K., Inoue O., Yamasaki T., Ido T., Nozaki T. Preparation of fluorine-18-labeled 6-fluoro-9-benzylpurine and 2-fluoro-9-benzylpurine as a potential brain scanning agent. Int. J. Appl. Radiat. Isot. 1982, 33:633-636.
239. 18F-labeled FIMPYD as a PET imaging agent for beta-amyloid plaques. J. Label. Compds Radiopharm. 2005, 48:S41.
240. 18F]fluoro-1,3-thiazoles. J. Label. Compds Radiopharm. 2005, 48:S158.
241. Kaneko S., Ishiwata K., Hatano K., Omura H., Ito K., Senda M. Enzymatic synthesis of no-carrier-added 6-[F-18]fluoro-l-DOPA with beta-tyrosinase. Appl. Radiat. Isot. 1999, 50:1025-1032.
242. Eakins M.N., Somain S. 18F-Labelled amino acids as pancreatic scanning agents. J. Label. Compds Radiopharm. 1979, 16:148-149.
243. 18F]fluoro-alpha-d-glucose. J. Label. Compds Radiopharm. 1999, 42:S111.
244. Gribble G.W. Natural organohalogens: A new frontier for medicinal agents?. J. Chem. Educ. 2004, 81:1441-1449.
245. Gribble G.W. The diversity of naturally produced organohalogens. Chemosphere 2003, 52:289-297.
246. Vaillancourt F.H., Yeh E., Vosburg D.A., Garneau-Tsodika S., Walsh C. Nature's inventory of halogenation catalysts: Oxidative strategies predominate. Chem. Rev. 2006, 106:3364-3378.
247. O'Hagan D., Schaffrath C., Cobb S.L., Hamilton J.T.G., Murphy C.D. Biosynthesis of an organofluorine molecule. Nature 2002, 416:279.
248. Dong C., Huang F., Deng H., Schaffrath C., Spencer J., O'Hagan D., Naismith J.H. Crystal structure and mechanism of a bacterial fluorinating enzyme. Nature 2004, 427:561-565.
249. N2 reaction mechanism. ChemBioChem 2004, 5:685-690.
250. Martarello L., Schaffrath C., Deng H., Gee A.D., Lockhart A., O'Hagan D. The first enzymatic method for C-F-18 bond formation: The synthesis of 5?-[F-18]-fluoro-5?-deoxyadenosine for imaging with PET. J. Label. Compds Radiopharm. 2003, 46:1181-1189.
251. Deng H., Cobb S.L., Gee A.D., Lockhart A., Martarello L., McGlinchey R.P., O'Hagan D., Onega M. Fluorinase mediated C-F-18 bond formation, an enzymatic tool for PET labelling. Chem. Comm. 2006, 652-654.
252. Wester H.J., Hamacher K., Stöcklin G. A comparative study of N.C.A. fluorine-18 labeling of proteins via acylation and photoactivation. Nucl. Med. Biol. 1996, 23:365-372.
253. 18F]fluorobenzoate. Nucl. Med. Biol. 1992, 19:275-281.
254. 18F]fluorobenzoate and its application to the labeling of monoclonal antibody fragment. Bioconj. Chem. 1994, 5:352-356.
255. 18F]fluorobenzoyl octreotide and biodistribution in tumor-bearing Lewis rats. J. Label. Compds Radiopharm. 1999, 42:S720-S722.
256. 18F-Fluoroacetate: An agent for introducing no-carrier-added fluorine-18 into urokinase without loss of biological activity. J. Label. Compds Radiopharm. 1982, 19:1645-1646.
257. 18F-Fluoroacylation via fluorocarboxylic acid esters. J. Label. Compds Radiopharm. 1988, 15:185-200.
258. 18F]-N-succinimidyl 4-(fluoromethyl)benzoate for protein labelling. Appl. Radiat. Isot. 1994, 45:1155-1163.
259. 18F]fluoromethyl)benzoate. Appl. Radiat. Isot. 1997, 48:169-173.
260. Garg P.K., Garg S., Bigner D.D., Zalutsky M.R. Fluorine-18 labeling of monoclonal antibodies and fragments with preservation of immunoreactivity. Bioconj. Chem. 1991, 2:44-49.
261. 18F]arylnitrene. J. Nucl. Med. 1994, 35:73P.
262. 18F labelling of proteins. Nucl. Med. Biol. 1994, 21:1005-1010.
263. 18F-labeled insulin: A prosthetic group methodology for incorporation of a positron emitter into peptides and proteins. Biochem. 1989, 28:4801-4806.
264. Brinkley M. A brief survey of methods for preparing protein conjugates with dyes, haptens, and cross-linking reagents. Bioconj. Chem. 1992, 3:2-13.
265. Hermanson G.T. Bioconjugate Techniques 1996, Academic Press, San Diego (CA).
266. 18F. J. Label. Compds Radiopharm. 1989, 26:287-289.
267. 18F-labeling agent. Bioconj. Chem. 2003, 14:1253-1259.
268. 18F-fluorobenzamido)ethyl]maleimide, and synthesis of RGD peptide-based tracer for PET imaging of alpha-v-beta-3-integrin expression. J. Nucl. Med. 2006, 47:1172-1180.
269. 18F]labeled maleimides, their use for marking macromolecules for medical imaging. PCT Int. Appl. 2004, 58. WO 2004002984.
270. Nielsen P.E., Egholm M., Berg R.H., Buchardt O. Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science 1991, 254:1497-1500.
271. Nielsen P.E., Egholm M. Peptide Nucleic Acids: Protocols and Applications 1999, Horizon Scientific Press, Norfolk.
272. Kuhnast B., Dollé F., Tavitian B. Fluorine-18 labeling of peptide nucleic acids. J. Label. Compds Radiopharm. 2001, 45:1-11.
273. Hamzavi R., Dollé F., Tavitian B., Dahl O., Nielsen P. Modulation of the pharmacokinetic properties of PNA: Preparation of galactosyl, mannosyl, fucosyl, N-acetylgalactosaminyl and N-acetylglucosaminyl derivatives of aminoethylglycine peptide nucleic acid monomers and their incorporation into PNA oligomers. Bioconj. Chem. 2003, 14:941-954.
274. Kuhnast B., Hinnen F., Hamzavi R., Boisgard R., Tavitian B., Nielsen P.E., Dollé F. Fluorine-18 labelling of PNAs functionalized at their pseudo-peptidic backbone for imaging studies with PET. J. Label. Compds Radiopharm. 2005, 48:51-61.
275. Poethko T., Schottelius M., Thumshirn G., Hersel U., Herz M., Henriksen G., Kessler H., Schwaiger M., Wester H.J. Two-step methodology for high-yield routine radiohalogenation of peptides: 18F-Labeled RGD and octreotide analogs. J. Nucl. Med. 2004, 45:892-902.
276. Poethko T., Schottelius M., Thumshirn G., Hersel U., Herz M., Haubner R., Henriksen G., Kessler H., Schwaiger M., Wester H.J. Chemoselective pre-conjugate radiohalogenation of unprotected mono- and multimeric peptides via oxime formation. Radiochim. Acta 2004, 92:317-327.
277. 18F]fluoromethyl)phenyl isothiocyanate and its use in labeling oligonucleotides. Acta Chem. Scand. 1997, 51:1236-1240.
278. 18F]fluorobenzoate. Acta Chem. Scand. 1998, 52:1034-1039.
279. 18F]fluoride to an oligonucleotide aptamer. J. Label. Compds Radiopharm. 2002, 45:257-268.
280. 18F]fluorobenzyl)-2-bromoacetamide reagent. J. Label. Compds Radiopharm. 2003, 46:1093-1103.
281. Kuhnast B., Klussmann S., Hinnen F., Boisgard R., Rousseau B., Fürste J.P., Tavitian B., Dollé F. Fluorine-18- and iodine-125 labelling of Spiegelmers. J. Label. Compds Radiopharm. 2003, 46:1205-1219.
282. Marzabal S., Terrazzino S., Kuhnast B., Dollé F., Deverre J.R., Jobert A., Crouzel C., DiGiamberardino L., Tavitian B. In vivo imaging and pharmacokinetics of oligonucleotides. Nucleosides Nucleotides 1999, 18:1731-1733.
283. Tavitian B., Marzabal S., Boutet V., Kuhnast B., Terrazzino S., Moynier M., Dollé F., Deverre J.R., Thierry A.R. Characterization of a synthetic anionic vector for oligonucleotide delivery using in vivo whole body dynamic imaging. Pharm. Res. 2002, 19:367-376.
284. 18F-labelled Spiegelmers: A new class of oligonucleotidic radiopharmaceuticals. Eur. J. Nucl. Med. Mol. Imaging 2005, 32:470-477.
285. Nolte A., Klussmann S., Bald R., Erdmann V., Fürste J.P. Mirror-design of L-oligonucleotide ligands binding to L-arginine. Nat. Biotech. 1996, 14:1116-1119.
286. Wlotzka B., Leva S., Eschgfäller B., Burmeister J., Kleinjung F., Kaduk C., Muhn P., Hess-Stumpp H., Klussmann S. In vivo properties of an anti-GnRH Spiegelmer: An example of an oligonucleotide-based therapeutic substance class. Proc. Nat. Acad. Sci. USA 2002, 99:8898-8902.